Publications by authors named "F Rothenberg"

Diabetes is a major risk factor for cardiovascular disease, yet until now treatments for diabetes had only a modest impact on cardiovascular events. New interventions for patients with type 2 diabetes mellitus (oral empagliflozin and injectable liraglutide) are associated with unprecedented reductions in composite cardiovascular outcomes that seem disproportionate to the impact on glycated hemoglobin. This review examines in detail the recent trials that arrived at these conclusions, limitations of these studies, and how these outcomes may influence patient management in the future.

View Article and Find Full Text PDF

Non-cardiac critically ill patients with type II myocardial infarction (MI) have a high risk of mortality. There are no evidence-based interventions to mitigate this risk. We systematically reviewed the literature regarding the use of medications known to reduce mortality in patients with cardiac troponin (cTn) elevation due to type I MI (β blockers, statin, and aspirin) in studies of critically ill patients without Type I MI.

View Article and Find Full Text PDF

Background: Elevated cardiac troponin (cTn) in the absence of acute coronary syndromes (ACS) is associated with increased mortality in critically ill patients. There are no evidence-based interventions that reduce mortality in this group.

Objectives: We performed a retrospective investigation of the Veterans Administration Inpatient Evaluation Center database to determine whether drugs used in ACS (β-blockers, aspirin, and statins) are associated with reduced mortality in critically ill patients.

View Article and Find Full Text PDF

The biophysical effects of blood flow are known to influence the structure and function of adult cardiovascular systems. Similar effects on the maturation of the cardiovascular system have been difficult to directly and non-invasively measure due to the small size of the embryo. Optical coherence tomography (OCT) has been shown to provide high spatial and temporal structural imaging of the early embryonic chicken heart.

View Article and Find Full Text PDF
Article Synopsis
  • Adipose tissue depots, including perivascular adipocytes, vary in function and influence disease processes differently, but the role of perivascular adipocytes in vascular disease is not fully understood.
  • Perivascular adipocytes from human coronary regions show reduced adipocytic differentiation, lower anti-inflammatory adiponectin levels, and higher pro-inflammatory cytokines compared to subcutaneous and visceral adipocytes.
  • In mouse models, high-fat diets further reduce the expression of beneficial adipocyte genes and increase inflammatory signals in perivascular adipose tissue, suggesting that these cells play a unique role in connecting metabolic issues to inflammation in blood vessels.
View Article and Find Full Text PDF